Stéphane Jaisson
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Nephrology top 2%
- Dialysis and Renal Disease Management
- Chronic Kidney Disease and Diabetes
Papers in
-
- Advanced Glycation End Products research 22
- Metabolism and Genetic Disorders 5
-
- Metabolomics and Mass Spectrometry Studies 6
- S100 Proteins and Annexins 4
- Co-authors
- Philippe Gillery (57 shared papers)Christine Piétrement (16 shared papers)Laëtitia Gorisse (15 shared papers)Nathalie Leroy (9 shared papers)Vincent Vuiblet (4 shared papers)Laurent Duca (5 shared papers)Emile Van Schaftingen (2 shared papers)Maria Veiga‐da‐Cunha (2 shared papers)
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (7 papers)Diabetes & Metabolism (3 papers)Clinica Chimica Acta (2 papers)Proceedings of the National Academy of Sciences (2 papers)Biochemia Medica (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Stéphane Jaisson
68 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 118
- Clinical Biochemistry 348
- Nephrology 202
- Aging 31
- Internal Medicine 48
- Endocrinology, Diabetes and Metabolism 216
Countries citing papers authored by Stéphane Jaisson
This map shows the geographic impact of Stéphane Jaisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Jaisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Jaisson more than expected).
Fields of papers citing papers by Stéphane Jaisson
This network shows the impact of papers produced by Stéphane Jaisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Jaisson. The network helps show where Stéphane Jaisson may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Jaisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 142 | |
| 2 | 2011 | 120 | |
| 3 | 2010 | 99 | |
| 4 | 2006 | 78 | |
| 5 | 2002 | 76 | |
| 6 | 2017 | 55 | |
| 7 | 2018 | 54 | |
| 8 | 2013 | 50 | |
| 9 | 2014 | 44 | |
| 10 | 2007 | 44 | |
| 11 | 2014 | 43 | |
| 12 | 2009 | 43 | |
| 13 | 2012 | 42 | |
| 14 | 2006 | 42 | |
| 15 | 2017 | 41 | |
| 16 | 2004 | 40 | |
| 17 | 2013 | 39 | |
| 18 | 2014 | 37 | |
| 19 | 2014 | 33 | |
| 20 | 2013 | 31 |
About Stéphane Jaisson
Stéphane Jaisson is a scholar working on Clinical Biochemistry, Molecular Biology, Endocrinology, Diabetes and Metabolism, Immunology and Nephrology, having authored 72 papers that have together received 1.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (22 papers), Metabolomics and Mass Spectrometry Studies (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Metabolism and Genetic Disorders (5 papers), Muscle metabolism and nutrition (4 papers), Chronic Kidney Disease and Diabetes (4 papers) and S100 Proteins and Annexins (4 papers). The work is most often cited by research in Clinical Biochemistry (348 citations), Nephrology (202 citations), Aging (31 citations), Internal Medicine (48 citations) and Endocrinology, Diabetes and Metabolism (216 citations). Stéphane Jaisson has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Philippe Gillery, Christine Piétrement, Laëtitia Gorisse, Nathalie Leroy, Vincent Vuiblet, Laurent Duca, Emile Van Schaftingen, Maria Veiga‐da‐Cunha, Laurent Debelle and Christian E.H. Schmelzer. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), Diabetes & Metabolism, Clinica Chimica Acta, Proceedings of the National Academy of Sciences and Biochemia Medica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.